GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
32.70
-1.28 (-3.77%)
Aug 14, 2025, 11:45 AM - Market open
GRAIL Employees
GRAIL had 1,000 employees as of December 31, 2024. The number of employees decreased by 360 or -26.47% compared to the previous year.
Employees
1,000
Change (1Y)
-360
Growth (1Y)
-26.47%
Revenue / Employee
$134,285
Profits / Employee
-$442,952
Market Cap
1.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GRAL News
- 1 day ago - GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - GRAIL Reports Second Quarter 2025 Financial Results - PRNewsWire
- 14 days ago - GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference - PRNewsWire
- 15 days ago - GRAIL to Announce Second Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - The Holy Grail of Automation: Now a Robot Can Unload a Truck - WSJ
- 2 months ago - Grail Shares Jump on Promising Results for Galleri Study - Market Watch
- 2 months ago - GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study - PRNewsWire
- 2 months ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire